House Struggles To Stay Unified On H.R. 3; Timing Of Senate Drug Pricing Bill Up In Air

By John Wilkerson / September 15, 2021 at 10:12 AM
House Democratic leaders early Wednesday lacked the votes needed to pass their drug pricing bill (H.R. 3) out of the Energy & Commerce Committee, and Democrats in the Senate gave no indication on Tuesday (Sept. 14) that they are on the cusp releasing their alternative Medicare drug price negotiation bill, despite the Sept. 15 deadline for Senate committees to finish writing their parts of reconciliation legislation. Both House Ways & Means and Energy & Commerce recessed Tuesday before marking up...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.